RISK OF HYPOGLYCAEMIA WITH ALTERNATE-DAY GROWTH HORMONE INJECTIONS
- 1 May 1987
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 329 (8540), 1002-1004
- https://doi.org/10.1016/s0140-6736(87)92270-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effect of insulin on growth hormone-induced metabolic derangements in diabetesMetabolism, 1986
- Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.JCI Insight, 1986
- Actions of Insulin-Like Growth FactorsAnnual Review of Physiology, 1985
- Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (nsila) in human serumInternational Journal of Biochemistry, 1983
- Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilizationDiabetes, 1982
- SomatomedinsNew England Journal of Medicine, 1980
- Inhibition of the Action of Nonsuppressible Insulin-Like Activity on Isolated Rat Fat Cells by Binding to its Carrier ProteinJCI Insight, 1979
- Primary structure of human insulin‐like growth factor IIFEBS Letters, 1978
- NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heartDiabetologia, 1978
- STUDIES ON HUMAN GROWTH HORMONE. II. THE PHYSIOLOGICAL DISPOSITION AND METABOLIC FATE OF HUMAN GROWTH HORMONE IN MAN*JCI Insight, 1962